In PANC-1 pancreatic ductal adenocarcinoma cells, we knocked out the R273H endogenous mutant p53 using the CRISPR-Cas9 system (Figure 1A and Figure S1). Here, TP53 is linked to pancreatic ductal adenocarcinoma.